ClinicalTrials.gg
Active, not recruitingNCT01799967MISGEJUpdated Jan 30, 2026

Minimally Invasive Surgery of the Gastro-esophageal Junction

An observational study in Achalasia, Paraesophageal Hernia and GERD, sponsored by Ottawa Hospital Research Institute. Active, not recruiting at 1 site in Canada. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-01-30.

Sponsored by Ottawa Hospital Research Institute · Observational

Study type
Observational
Model
Cohort
Time perspective
Prospective
Enrollment
200
Ages
18 Years and older
Sex
All
01

Study summary

This study will assess short and long term outcomes of individuals undergoing minimally invasive surgery of the gastro-esophageal junction (MISGEJ). Patients will respond to questionnaires on an annual basis evaluating quality of life and functionality following MISGEJ. Hospital charts will also be reviewed on an annual basis to assess patient health outcomes.

02

Conditions studied

  • Achalasia
  • Paraesophageal Hernia
  • GERD
  • Epiphrenic Diverticula
  • Zenker's Diverticulum

Keywords

  • gastro-esophageal junction
  • minimally invasive
  • Achalasia
  • Paraesophageal hernia
  • GERD
  • Epiphrenic diverticula
  • Zenker's diverticulum
  • All minimally invasive surgeries of the gastro-esophageal junction
03

In context

Esophageal Achalasia

143 studies on the registry are indexed under Esophageal Achalasia; 44 are open to participants now.

This study's planned enrollment of 200 is above the median of 111 across 41 observational studies indexed under Esophageal Achalasia.

Browse Esophageal Achalasia studies →

Lead sponsor

Ottawa Hospital Research Institute is the lead sponsor of 547 studies on the registry; 99 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Non-probability sample

Study population

All patients undergoing minimally invasive surgery of the gastro-esophageal junction at the Ottawa Hospital.

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • All patients at the Ottawa Hospital undergoing minimally invasive surgery of the GEJ

Exclusion criteria

Exclusion Criteria:

  • Less than 18 years of age.
05

Study design

Observational model
Cohort
Time perspective
Prospective
Enrollment
200 participants (estimated)
06

What researchers measure

Primary outcomes

  1. MISGEJ symptoms (subjective)

    MISGEJ symptom questionnaire evaluated on an annual basis

    Time frame: 8 years

  2. Achalasia Disease Severity (subjective)

    Achalasia Disease Severity questionnaire evaluated on an annual basis.

    Time frame: 8 years

  3. Diagnostic imaging

    Patient x-rays, upper GI tests, Endoscopy, and/or CT scans will be assessed on an annual basis to objectively measure functionality and health status.

    Time frame: 8 years

07

Study locations

1 site
08

References and documents

Individual participant data

Plan to share: Undecided

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
Not marked actual or estimatedDates not marked actual or estimated

The record gives a start of Nov 2007, a primary completion of Nov 2027 and a completion of Nov 2027. It does not say whether these dates are actual or estimated.

How these figures are worked out, and which studies are left out of them.

Registered
Feb 25, 2013
First posted
Feb 27, 2013
Start
Nov 2007
Primary completionEst.
Nov 2027
CompletionEst.
Nov 2027
Last update
Jan 30, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Jan 30, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT01799967
Responsible party
Sponsor
First posted
Feb 27, 2013
Start date
Nov 2007
Primary completion
Nov 2027 (estimated)
Completion
Nov 2027 (estimated)
Last update
Jan 30, 2026

Study contacts

Andrew JE Seely, MD, PhD
principal investigator · Ottawa Hospital Research Institute

Oversight

Data monitoring committee
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is active, not recruiting, as verified in Dec 2024. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion